Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation

P Vandenberghe; N Boeckx; E Ronsyn; R Decorte; G Verhoef; A Hagemeijer

首页> 外文期刊>Leukemia >Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation

【24h】

Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation

机译：甲磺酸伊马替尼诱导异基因骨髓移植后持续持续的晚期CML完全缓解

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia》 |2003年第2期|共3页
作者
P Vandenberghe; N Boeckx; E Ronsyn; R Decorte; G Verhoef; A Hagemeijer;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-18 12:14:28

相似文献

外文文献
中文文献
专利

1. Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantation. [J] . Wassmann B, Scheuring U, Thiede C, Bone marrow transplantation . 2003,第7期

机译：异基因干细胞移植后，甲磺酸伊马替尼（STI571）诱导的CML淋巴样高危复发的患者稳定的分子缓解。
2. Ph-Negative Isolated Myeloid Sarcoma With NPM1 Gene Mutation in Adolescent With Ph-positive Chronic Myeloid Leukemia in Remission After Treatment With Allogeneic Bone Marrow Transplantation and Imatinib Mesylate [J] . Skalska-Sadowska Jolanta, Januszkiewicz-Lewandowska Danuta, Derwich Katarzyna, Pediatric blood & cancer . 2015,第6期

机译：异基因骨髓移植和甲磺酸伊马替尼治疗后Ph阳性慢性粒细胞白血病缓解的Ph阴性孤立性髓样肉瘤，NPM1基因突变
3. Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study. [J] . Hess G, Bunjes D, Siegert W, Journal of Clinical Oncology . 2005,第30期

机译：异基因干细胞移植治疗慢性粒细胞白血病后失败的患者接受甲磺酸伊马替尼治疗后维持完全分子缓解：一项前瞻性II期开放标签多中心研究的结果。
4. Nuclear Entrapment of the BCR-ABL Oncoprotein by the Combination of Imatinib Mesylate and Leptomycin B Kills CML Cells [C] . P. Vigneri, A. Aloisi, S. Di Gregorio, International conference on tumor microenvironment . 2004

机译：通过伊马替尼甲磺酸伊替尼酸甲磺酸盐和百霉素B的组合核截留BCR-ABL癌蛋白杀死CML细胞
5. Antigen Specific Induced T Regulatory Cellular Therapy for Graft-Versus-Host Disease Following Allogeneic Bone Marrow Transplantation. [D] . Heinrichs, Jessica Lauren. 2016

机译：异体骨髓移植后针对移植物抗宿主病的抗原特异性诱导T调节细胞疗法。
6. Durable Leukemic Remission and Autologous Marrow Recovery with Random Chromosomal Abnormalities after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia [O] . Hidekazu Nishikii, Naoki Kurita, Atsushi Shinagawa, 2019

机译：异基因造血干细胞移植治疗慢性淋巴细胞白血病后的持久性白血病缓解和自体骨髓恢复及随机染色体异常
7. Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation [O] . Vandenberghe, Peter, Boeckx, Nancy, Ronsyn, Elke, 2003

机译：甲磺酸伊马替尼诱导异基因骨髓移植后持续持续的晚期CML完全缓解

Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation

著录项

相似文献

相关主题

期刊订阅